A "groundbreaking" drug is being trialled in the first Brits to cure autoimmune conditions such as lupus and multiple ...

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...

Potential New Drug Treatment for Multiple Sclerosis Dec. 8, 2023 — Pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis ...

Opens in a new tab or window The quest to understand and slow disease progression in multiple sclerosis (MS) continued in ...

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...

Medication and cognitive behavioral therapy can both help fight MS-related fatigue. A person’s sleep habits did play a role.

Biogen raised its annual profit forecast on Wednesday, as new treatments and cost-cutting measures offset declining sales of ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

Even though Biogen raised earnings guidance, the company still has “some potentially concerning signals” in its base business ...

The groundbreaking new NHS lupus therapy works by genetically modifying cells to enable the body's immune system to recognise ...

Developing a more comprehensive understanding of the interactions between the brain, blood vessels, and the immune system ...

Biogen raised its annual profit forecast and exceeded expectations for third-quarter profit on Wednesday, as new treatments ...